# K052183: Soring GMBH Sonoca Lipo

- Pathway: 510(k) (Traditional)
- Applicant: Soring GmbH Medizintechnik
- Decided: Oct 7, 2005 after 58 days
- Product code: QPB (System, Suction, Lipoplasty For Removal)
- Device class: 2
- Regulation: 21 CFR 878.5040
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K910696 (1991). 22 ancestors in all.
3 later devices descend from it; 1 cites it directly.
0 of 26 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K992026: Soring GMBH, Sonoca 300, Soring GmbH Medizintechnik (1999) Summary page 5.
- K041058: Misonix Inc. Lysonix 2000/3000 Ultrasonic Surgical Aspirator Systems, Misonix, Inc. (2004) Summary page 5.

## Most influential descendants
- K092066: Phaser Lipoplasty System (Dur-01), Phaser Disposable Kit (Dis-01), Phaser Waste Collection Kit (Was-01), Phaser Cannulae (2010), 2 descendants of its own
- K121218: Hydrasolve Console Sterile Treatment Kit Reusable Cannula, 4MM Dia, 26 CM Length, 3 Aperture Reusable Cannula, 4MM Dia, (2012), 1 descendant of its own
- K130152: Hydrasolve Lipoplasty System (2013), 0 descendants of its own

## Indications for use
The SONOCA Lipo is an instrument indicated for selected ultrasound dissection, liquefaction, emulsifying and aspiration of soft tissues in General Surgery, Plastic and Reconstructive Surgery, and Gynecological Surgery applications. It is also indicated for the liquefaction and aspiration of localized subcutaneous fatty tissue for aesthetic body contouring. Typical users of this system are trained medical professionals.

Source page: https://510kreport.com/device/K052183
Methodology: https://510kreport.com/methodology
